Clinical Trial Update: Optimal Haloperidol Dose for Postoperative Nausea and Vomiting Prevention in High-risk Patients [NA]

View source ↗

Summary

Clinical trial update evaluating the optimal dose of haloperidol for preventing postoperative nausea and vomiting in high-risk patients with gynecological disea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gynecological Disease

Drugs mentioned

• HALOPERIDOL (HALOPERIDOL LACTATE)

Snippet

Sponsor: The Catholic University of Korea | Conditions: Gynecological Disease | NA | Status: COMPLETED | Results posted: 2020-08-24